Publications by authors named "Sumit Subudhi"

Claim this Profile
C
Continuous Androgen Deprivation Therapy with or Without Metastasis-directed Therapy for Oligometastatic Prostate Cancer: The Multicenter Phase 2 Randomized EXTEND Trial.
Alexander D Sherry, Bilal A Siddiqui, Cara Haymaker, Bryan M Fellman, Marina N Medina-Rosales, Sumit K Subudhi

Eur Urol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating Clinical Tools to Monitor Cardiovascular Risk in Men With Prostate Cancer Receiving Hormone Therapy.
Neha Venkatesh, Pankaj Kumar Chauhan, Sagar S Mukhida, Kabir Grewal, Ana Aparicio, Sumit K Subudhi

JCO Oncol Pract· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neuropsychiatric events following high-dose steroid administration during early immune checkpoint therapy are more frequent with extended steroid exposure.
Tamara E Lacourt, Marc C Schubert, Bilal A Siddiqui, Sumit K Subudhi, Deepti A Chopra

Support Care Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrating systemic therapy and metastasis-directed therapy in oligometastatic hormone-sensitive prostate cancer.
Xiaolei Shi, Jarey H Wang, Brian F Chapin, Ana Aparicio, Sumit K Subudhi

Prostate Cancer Prostatic Dis· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Body composition as a determinant of the therapeutic index with androgen signaling inhibition.
Andrew W Hahn, Rebecca S Tidwell, Patrick G Pilie, Yao Yu, Jingjing Liu, Sumit K Subudhi

Prostate Cancer Prostatic Dis· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a leucine-rich repeat-containing protein 15-targeted radio-immunotheranostic approach to deplete pro-tumorigenic mechanisms and immunotherapy resistance.
Claire M Storey, Mohamed Altai, Katharina Lückerath, Wahed Zedan, Henan Zhu, Sumit K Subudhi

Signal Transduct Target Ther· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subclonal mutation load predicts survival and response to immunotherapy in cancers with low to moderate tumor mutation burden.
Yujie Jiang, Matthew D Montierth, Kaixian Yu, Shuangxi Ji, Quang Tran, Sumit K Subudhi

bioRxiv· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perspectives on the role of "-Omics" in predicting response to immunotherapy.
Anna Maria Di Giacomo, Sumit Subudhi, Wim Vos, Massimo Andreatta, Santiago Carmona

Eur J Cancer· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, Efficacy, and Adjacent-level Fracture Risk Following Vertebral Augmentation and Radiofrequency Ablation for the Treatment of Spine Metastases in Patients with Cancer.
Jeremiah Stringam, Koustav Pal, Andrew Niekamp, Rahim Jiwani, Iwan Paolucci, Sumit K Subudhi

Radiol Imaging Cancer· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and Translational Results from PORTER, a Multicohort Phase I Platform Trial of Combination Immunotherapy in Metastatic Castration-Resistant Prostate Cancer.
Matthew D Galsky, Karen A Autio, Christopher R Cabanski, Kristopher Wentzel, Julie N Graff, Sumit K Subudhi

Clin Cancer Res· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Society for Immunotherapy of Cancer (SITC) consensus statement on essential biomarkers for immunotherapy clinical protocols.
Tricia R Cottrell, Michael T Lotze, Alaa Ali, Carlo B Bifulco, Christian M Capitini, Sumit K Subudhi

J Immunother Cancer· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Body composition in recurrent prostate cancer and the role of steroidogenic genotype.
Neha Venkatesh, Rebecca S Tidwell, Yao Yu, Ana Aparicio, Amado J Zurita, Sumit K Subudhi

Endocr Relat Cancer· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PSCA-targeted BPX-601 CAR T cells with pharmacological activation by rimiducid in metastatic pancreatic and prostate cancer: a phase 1 dose escalation trial.
Mark N Stein, Ecaterina E Dumbrava, Benjamin A Teply, Usama S Gergis, Martin E Guiterrez, Sumit K Subudhi

Nat Commun· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of positron emission tomography for the diagnosis of immune-checkpoint inhibitor| myocarditis.
Abdelrahman Ali, Yang Lu, Shaden Khalaf, Cezar Iliescu, Efstratios Koutroumpakis, Sumit K Subudhi

J Nucl Cardiol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular Pathways and Cellular Subsets Associated with Adverse Clinical Outcomes in Overlapping Immune-Related Myocarditis and Myositis.
Bilal A Siddiqui, Nicolas L Palaskas, Sreyashi Basu, Yibo Dai, Zhong He, Sumit K Subudhi

Cancer Immunol Res· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Modular Trial of Androgen Signaling Inhibitor Combinations Testing a Risk-Adapted Strategy in Patients with Metastatic Castration-Resistant Prostate Cancer.
Ana M Aparicio, Rebecca S S Tidwell, Shalini S Yadav, Jiun-Sheng Chen, Miao Zhang, Sumit K Subudhi

Clin Cancer Res· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrative Molecular Analyses of the MD Anderson Prostate Cancer Patient-derived Xenograft (MDA PCa PDX) Series.
Nicolas Anselmino, Estefania Labanca, Peter D A Shepherd, Jiabin Dong, Jun Yang, Sumit K Subudhi

Clin Cancer Res· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a Strategic Initiative at MD Anderson Cancer Center to Improve Outcomes in Immune-Related Adverse Events.
Sarah E Fayle, Nicolas L Palaskas, Bilal A Siddiqui, Jennifer L McQuade, Jamie S Lin, Sumit K Subudhi

J Natl Compr Canc Netw· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the Aggressive-Variant Prostate Cancer Molecular Signature in Clinical Laboratory Improvement Amendments (CLIA) Environments.
Paul V Viscuse, Rebecca S Slack-Tidwell, Miao Zhang, Prih Rohra, Keyi Zhu, Sumit K Subudhi

Cancers (Basel)· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiometabolic healthcare for men with prostate cancer: an MD Anderson Cancer Center experience.
Andrew W Hahn, Whittney Thoman, Efstratios Koutroumpakis, Amer Abdulla, Sumit K Subudhi

Cardiooncology· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination Treatment with Sipuleucel-T and Abiraterone Acetate or Enzalutamide for Metastatic Castration-Resistant Prostate Cancer: STAMP and STRIDE Trials.
Emmanuel S Antonarakis, Sumit K Subudhi, Christopher M Pieczonka, Lawrence I Karsh, David I Quinn

Clin Cancer Res· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune checkpoint therapy-current perspectives and future directions.
Padmanee Sharma, Sangeeta Goswami, Deblina Raychaudhuri, Bilal A Siddiqui, Pratishtha Singh, Sumit K Subudhi

Cell· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune and pathologic responses in patients with localized prostate cancer who received daratumumab (anti-CD38) or edicotinib (CSF-1R inhibitor).
Bilal A Siddiqui, Brian F Chapin, Sonali Jindal, Fei Duan, Sreyashi Basu, Sumit K Subudhi

J Immunother Cancer· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-PD-L1 plus enzalutamide does not improve overall survival in prostate cancer.
Bilal A Siddiqui, Sumit K Subudhi, Padmanee Sharma

Cell Rep Med· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A composite T cell biomarker in pre-treatment blood samples correlates with detection of immune-related adverse events.
Sangeeta Goswami, Bilal A Siddiqui, Sumit K Subudhi, Sreyashi Basu, Shalini S Yadav

Cancer Cell· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis